Seizert Capital Partners LLC raised its holdings in The Cigna Group (NYSE:CI – Free Report) by 203.0% in the 3rd quarter, HoldingsChannel reports. The fund owned 125,529 shares of the health services provider’s stock after acquiring an additional 84,096 shares during the period. The Cigna Group comprises approximately 2.0% of Seizert Capital Partners LLC’s holdings, making the stock its 18th biggest position. Seizert Capital Partners LLC’s holdings in The Cigna Group were worth $43,488,000 at the end of the most recent reporting period.
Several other large investors have also recently modified their holdings of the business. Turtle Creek Wealth Advisors LLC increased its stake in shares of The Cigna Group by 3.5% in the third quarter. Turtle Creek Wealth Advisors LLC now owns 15,261 shares of the health services provider’s stock valued at $5,287,000 after buying an additional 510 shares during the period. KPP Advisory Services LLC boosted its holdings in The Cigna Group by 8.6% in the third quarter. KPP Advisory Services LLC now owns 1,277 shares of the health services provider’s stock valued at $442,000 after acquiring an additional 101 shares during the last quarter. Linscomb Wealth Inc. boosted its holdings in The Cigna Group by 1.6% in the third quarter. Linscomb Wealth Inc. now owns 10,508 shares of the health services provider’s stock valued at $3,641,000 after acquiring an additional 170 shares during the last quarter. Simplify Asset Management Inc. increased its position in The Cigna Group by 328.3% during the 3rd quarter. Simplify Asset Management Inc. now owns 20,933 shares of the health services provider’s stock valued at $7,252,000 after purchasing an additional 16,045 shares during the period. Finally, KCM Investment Advisors LLC raised its holdings in The Cigna Group by 3.7% during the 3rd quarter. KCM Investment Advisors LLC now owns 2,169 shares of the health services provider’s stock worth $751,000 after purchasing an additional 77 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently commented on CI shares. Royal Bank of Canada reduced their price objective on shares of The Cigna Group from $384.00 to $377.00 and set an “outperform” rating on the stock in a research note on Friday, November 1st. JPMorgan Chase & Co. increased their price target on The Cigna Group from $435.00 to $438.00 and gave the stock an “overweight” rating in a report on Wednesday, August 21st. Piper Sandler reissued an “overweight” rating and issued a $394.00 price objective (up from $392.00) on shares of The Cigna Group in a research note on Tuesday, November 5th. Jefferies Financial Group raised their target price on The Cigna Group from $402.00 to $422.00 and gave the stock a “buy” rating in a research note on Tuesday, September 17th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $400.00 target price on shares of The Cigna Group in a report on Wednesday, October 23rd. One research analyst has rated the stock with a hold rating, fourteen have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus price target of $394.64.
The Cigna Group Stock Performance
NYSE CI opened at $321.52 on Friday. The company has a market cap of $89.43 billion, a P/E ratio of 30.33, a PEG ratio of 1.00 and a beta of 0.51. The company has a fifty day simple moving average of $338.88 and a 200 day simple moving average of $339.55. The company has a current ratio of 0.72, a quick ratio of 0.72 and a debt-to-equity ratio of 0.71. The Cigna Group has a 12-month low of $253.95 and a 12-month high of $370.83.
The Cigna Group (NYSE:CI – Get Free Report) last announced its quarterly earnings results on Thursday, October 31st. The health services provider reported $7.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.22 by $0.29. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. The business had revenue of $63.70 billion during the quarter, compared to the consensus estimate of $59.58 billion. During the same quarter in the prior year, the company posted $6.77 earnings per share. The Cigna Group’s revenue was up 29.8% compared to the same quarter last year. Sell-side analysts predict that The Cigna Group will post 28.5 earnings per share for the current fiscal year.
The Cigna Group Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 19th. Shareholders of record on Wednesday, December 4th will be paid a $1.40 dividend. The ex-dividend date of this dividend is Wednesday, December 4th. This represents a $5.60 annualized dividend and a yield of 1.74%. The Cigna Group’s dividend payout ratio (DPR) is 52.83%.
Insider Transactions at The Cigna Group
In related news, Director William J. Delaney III sold 2,691 shares of the business’s stock in a transaction dated Monday, August 19th. The shares were sold at an average price of $342.68, for a total value of $922,151.88. Following the transaction, the director now directly owns 17,539 shares of the company’s stock, valued at approximately $6,010,264.52. The trade was a 13.30 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 0.60% of the company’s stock.
The Cigna Group Profile
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Featured Stories
- Five stocks we like better than The Cigna Group
- Stock Average Calculator
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- Most Volatile Stocks, What Investors Need to Know
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- Consumer Discretionary Stocks Explained
- Time to Load Up on Home Builders?
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.